NEU 3.32% $20.52 neuren pharmaceuticals limited

Share Price Target IF approved., page-57

  1. 15,662 Posts.
    lightbulb Created with Sketch. 4019
    I've always enjoyed reports by E&P, I reckon they're pretty spot on with their valuations (as was evident in this case). Usually offer much more in-depth research and interesting insights which others fail to do

    If they're calling $17 I reckon that's pretty spot on, at least as a short term target. I'm sure it'll go much higher longer term!
    Last edited by TheAnalyst007: 14/03/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.